These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 33331525)
41. Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021. Lyimo E; Fougeroux C; Malabeja A; Mbwana J; Hayuma PM; Liheluka E; Turner L; Gesase S; Lavstsen T; Lusingu JPA; Minja DTR; Wang CW BMC Infect Dis; 2022 Nov; 22(1):846. PubMed ID: 36371172 [TBL] [Abstract][Full Text] [Related]
42. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival. Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620 [TBL] [Abstract][Full Text] [Related]
43. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL; Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883 [TBL] [Abstract][Full Text] [Related]
45. Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity? Banerjee A; Gaikwad B; Desale A; Jadhav SL; Rathod H; Srivastava K Indian J Public Health; 2021; 65(3):256-260. PubMed ID: 34558487 [TBL] [Abstract][Full Text] [Related]
46. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia. Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488 [TBL] [Abstract][Full Text] [Related]
47. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873 [TBL] [Abstract][Full Text] [Related]
48. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study. Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090 [TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey. Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464 [TBL] [Abstract][Full Text] [Related]
50. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves. Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848 [TBL] [Abstract][Full Text] [Related]
51. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet! Mveang Nzoghe A; Leboueny M; Kuissi Kamgaing E; Maloupazoa Siawaya AC; Bongho EC; Mvoundza Ndjindji O; Padzys GS; Ndeboko B; Ategbo S; Djoba Siawaya JF BMC Res Notes; 2021 Apr; 14(1):152. PubMed ID: 33879229 [TBL] [Abstract][Full Text] [Related]
52. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings. Buonsenso D; Valentini P; De Rose C; Pata D; Sinatti D; Speziale D; Ricci R; Carfì A; Landi F; Ferrari V; De Maio F; Palucci I; Sanguinetti M; Sali M; Pediatr Pulmonol; 2021 Jun; 56(6):1374-1377. PubMed ID: 33470561 [TBL] [Abstract][Full Text] [Related]
53. Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico. Basto-Abreu A; Carnalla M; Torres-Ibarra L; Romero-Martínez M; Martínez-Barnetche J; López-Martínez I; Aparicio-Antonio R; Shamah-Levy T; Alpuche-Aranda C; Rivera JA; Barrientos-Gutierrez T; Nat Commun; 2022 Feb; 13(1):589. PubMed ID: 35105873 [TBL] [Abstract][Full Text] [Related]
54. SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses. Gozlan Y; Reingold S; Koren R; Halpern O; Regev-Yochay G; Cohen C; Biber A; Picard O; Mendelson E; Lustig Y; Mor O Epidemiol Infect; 2021 Jun; 149():e153. PubMed ID: 34372950 [TBL] [Abstract][Full Text] [Related]
55. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan. Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D; Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289 [TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic. Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898 [TBL] [Abstract][Full Text] [Related]
58. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851 [TBL] [Abstract][Full Text] [Related]
59. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941 [TBL] [Abstract][Full Text] [Related]